Cargando…
Magnetic Resonance-based Response Assessment and Dose Adaptation in Human Papilloma Virus Positive Tumors of the Oropharynx treated with Radiotherapy (MR-ADAPTOR): An R-IDEAL stage 2a-2b/Bayesian phase II trial
BACKGROUND: Current standard radiotherapy for oropharynx cancer (OPC) is associated with high rates of severe toxicities, shown to adversely impact patients’ quality of life. Given excellent outcomes of human papilloma virus (HPV)-associated OPC and long-term survival of these typically young patien...
Ejemplares similares
-
Magnetic resonance guided elective neck irradiation targeting individual lymph nodes: A new concept
por: Reinders, Floris C.J., et al.
Publicado: (2021) -
Folic acid fortification and public health: Report on threshold doses above which unmetabolised folic acid appear in serum
por: Sweeney, Mary Rose, et al.
Publicado: (2007) -
Target Definition in MR-Guided Adaptive Radiotherapy for Head and Neck Cancer
por: de Ridder, Mischa, et al.
Publicado: (2022) -
Use of biosensors for the detection of marine toxins
por: McPartlin, Daniel A., et al.
Publicado: (2016) -
Individual elective lymph node irradiation for the reduction of complications in head and neck cancer patients (iNode): A phase-I feasibility trial protocol
por: Reinders, Floris C.J., et al.
Publicado: (2022)